- Home
- NEOV vs CDXS Comparison
NEOV vs CDXS Comparison
Compare NEOV & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NEOV | CDXS |
|---|---|---|
| Founded | 2018 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Major Chemicals |
| Sector | Miscellaneous | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 129.2M | 141.8M |
| IPO Year | N/A | 2010 |
Fundamental Metrics
Financial Performance| Metric | NEOV | CDXS |
|---|---|---|
| Price | $3.43 | $1.65 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 232.3K | ★ 1.0M |
| Earning Date | 11-10-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $14,486,857.00 | ★ $52,932,000.00 |
| Revenue This Year | $148.14 | $15.64 |
| Revenue Next Year | $6.34 | $5.23 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 486.23 | N/A |
| 52 Week Low | $1.80 | $1.52 |
| 52 Week High | $6.19 | $6.01 |
Technical Indicators
Market Signals| Indicator | NEOV | CDXS |
|---|---|---|
| Relative Strength Index (RSI) | 40.26 | 41.38 |
| Support Level | $3.35 | $1.62 |
| Resistance Level | $3.93 | $1.95 |
| Average True Range (ATR) | 0.32 | 0.09 |
| MACD | -0.02 | 0.02 |
| Stochastic Oscillator | 15.29 | 19.12 |
Price Performance
Historical ComparisonAbout NEOV NeoVolta Inc.
NeoVolta Inc is engaged in designing, manufacturing and sale of high end Energy Storage System which can store and use solar energy via batteries and an inverter at a residential site. Its market place includes solar industry, installers, new construction homebuilders, home remodelers and homeowners.
About CDXS Codexis Inc.
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.